Biologik ApS: Financial statements 2023
CVR: 36070498
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Biologik ApS (CVR 36070498) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 653,018 and a net result of DKK 118,661 compared with DKK -89,361 the year before. That is an increase of 153% compared with the year before. Equity in the 2023 report amounted to DKK 329,327. The solvency ratio was 71.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 653,018
- Profit/Loss
- DKK 118,661
- Equity
- DKK 329,327
- Total Assets
- DKK 463,092
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 653 t. | 119 t. | 329 t. | 1 |
| 2022 | - | 258 t. | -89 t. | 268 t. | 1 |
| 2021 | - | 593 t. | 215 t. | 414 t. | 1 |
| 2020 | - | 378 t. | 62 t. | 199 t. | 1 |
| 2019 | - | 832 t. | 183 t. | 237 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Biologik ApS
Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. Equity in the 2025 report amounted to DKK 408,578.